AFRM three-lens brief
Evidence-based stock research on AFRM. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +2.87% yesterday. · Trading >3% below the 50-day MA — short-term weakness.
- Moved +2.87% yesterday.
- Trading >3% below the 50-day MA — short-term weakness.
- P/E of 11.8 — trading at a value multiple.
- Analyst mean target $96.22 — 42% above current (34 analysts).
- Reported earnings on 2026-11-05.
AFRM closed at $67.84 (+2.87%) as of 2026-11-12. Market cap: $23.00B. P/E (trailing) 11.8. Price is below the 50-day MA and above the 200-day MA. Positives: moved +2.87% yesterday.; p/E of 11.8 — trading at a value multiple.. Concerns: trading >3% below the 50-day MA — short-term weakness.. Last quarter: Revenue $1.26B, net income $164.17M, free cash flow $878.72M.
Why three lenses on AFRM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AFRM across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AFRM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AFRM brief"></iframe>